Join
Live feed
·
PRReleasevia Quantisnow
Solid Biosciences Inc. logo

Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy

ByQuantisnow·Wall Street's wire, on your screen.
SLDB· Solid Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLDB (Solid Biosciences Inc.) and more on Quantisnow.